… patients with castration-resistant prostate cancer (CRPC), including radium … radioligand treatments in prostate cancer, the integration of … prior to getting docetaxel after they did … -metastatic-castration-resistant-prostate-cancer-indication FDA approves …

… progression to metastatic castration-resistant prostate cancer; the median time to … metastatic castration-resistant prostate cancer in these respective arms … in metastatic hormone-sensitive prostate cancer with and without Taxotere to meet patients …

… treated metastatic castration-resistant prostate cancer, according to results … [metastatic castration-resistant prostate cancer] with disease progression … plus docetaxel versus docetaxel for previously treated metastatic castration-resistant prostate cancer: …

… ) profiles between patients with prostate cancer receiving triplet therapy (docetaxel, androgen receptor signaling … prostate cancer (mCSPC) or metastatic castration-resistant prostate cancer (mCRPC) who were treated with docetaxel …

… resistant prostate cancer and neuroendocrine prostate cancer.2 … batiraxcept alone, docetaxel alone, carboplatin … -resistant prostate cancer and neuroendocrine prostate cancer. This … castration-resistant prostate cancers suggesting therapeutic targets …

… way to display the prostate cancer journey, all the … can include prostate radiotherapy, docetaxel. And this was presented … So high-risk, localized prostate cancer scheduled for surgery or … with a metastatic neuroendocrine prostate cancer with these features …

… capsules in hormone-refractory prostate cancer, 2-ME was … capsules in hormone-refractory prostate cancer. Clin Cancer Res. … -estradiol loaded nanocarrier for prostate cancer. Front Pharmacol. 2021; … enhance oral delivery of docetaxel. Pharmaceutics. 2022;14( …

… = 30) received DC-CIK plus docetaxel + cisplatin chemotherapy with concurrent conformal … such as NSCLC, melanoma, and prostate cancer, not all patients derive clinical … -T immunotherapy for castration-resistant prostate cancer. N Engl J Med. 2010 …

… move is going on docetaxel. There are many … if the patient got docetaxel for their up-front … pluvictos-metastatic-castration-resistant-prostate-cancer-indication Sartor AO, Castellano … with metastatic castration-resistant prostate cancer (PSMAfore). Ann Oncol. …

… in mHSPC with and without docetaxel to meet patients’ individual needs … patients with metastatic hormone-sensitive prostate cancer: phase 3 ARANOTE trial. Presented … patients with metastatic hormone-sensitive prostate cancer. News release. Bayer. November …